New Azido impurity Pharma Genotoxic Impurity application note on TSQ Quantis™ LC-MS/MS ⬇️
Key benefits
• A single method capable of detecting an azido impurity (AZBT) in six different
Sartan products—Candesartan, Irbesartan, Losartan, Olmesartan, Telmisartan, and Valsartan—saves time by testing multiple products in one sequence without separate
method development.
• A robust method for quantification of AZBT was achieved by using a divert valve to
prevent the mass spectrometer from the build-up of high concentrations of drug
product samples. This helped maintain good sensitivity and reproducibility.
• This study is in line with regulatory information and requirements mentioned in
EDQM1, USFDA (Q2B)2, EMEA3, and ICH M74 guidelines.
Link to application note ⬇️
Azido app note
Join our pharma community to learn more ⬇️
https://lnkd.in/dDqzE8J5
Join LinkedIn's largest Genotoxic Impurity Community ⬇️
https://lnkd.in/d57wRp4
Contact us for more information ⬇️
https://lnkd.in/dDnq7yqE
United States
